Investor Relations
Text Size: 
Text Size Large Text Size Medium Text Size Small
Print

Shareholder Return

Basic Policy on Shareholder Return:

The Company is aiming to sustained improvement in its enterprise value and return to shareholders. While putting priority on investment to assure future growth, the Company will also improve the level of return to shareholders. To this end, the Company will continuously increase dividend payments assuming growth in earnings on a consolodated basis over the medium- to long-term, and implement share buybacks in a proactive and flexible manner to improve capital efficiency. Based on these policies, the Company has a medium-term DOE target of 8% for fiscal 2010.
*DOE(dividend on equity) is calculated by multiplying ROE by payout ratio.


Dividend

  • Record Date for Dividend:
    Year-end dividend - March 31
    Interim dividend - September 30

  • Historical Data of Dividend
    (Unit: Yen / share)
    Fiscal 2005 Fiscal 2006 Fiscal 2007 Fiscal 2008
    Interim dividend 30 40 50 60(planned)
    Year-end dividend 40 40 60 60(planned)
    Annual dividend 70 80 110 120(planned)
    Note: In accordance with the Company's Articles of Incorporation, if cash dividends are not claimed for three (3) full years from the day of commencement of payment, the Company shall be relieved of the obligation to make such payment.


Share Buyback and Cancellation of Treasury Stock



Get Adobe Reader
To view and print the files, you must have Adobe Reader.

Disclaimer for Share Price Feed
The past performance of the price of securities must not be relied on as a guide to their future performance. Astellas pharma inc. has not reviewed, is not responsible for, and accepts no liability in respect of, any information or opinion contained on any other website.

For more detail information, please refer to Cautionary Statement.


Stock Quotes (TSE1st.: 4503)
Delayed 20min. (yen)
News Releases
Cautionary Statement
Disclosure Policy
Privacy Policy